Filing Details

Accession Number:
0001225208-17-010017
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-05-17 20:48:27
Reporting Period:
2017-05-16
Filing Date:
2017-05-17
Accepted Time:
2017-05-17 20:48:27
Original Submission Date:
2017-05-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
21665 Colgate Palmolive Co CL Perfumes, Cosmetics & Other Toilet Preparations (2844) 131815595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182210 M Ellen Hancock C/O Colgate-Palmolive Company
300 Park Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-15 5,780 $60.45 203,582 No 4 M Direct
Common Stock Acquisiton 2017-05-15 2,512 $0.00 206,094 No 4 A Direct
Common Stock Disposition 2017-05-15 4,920 $71.75 201,174 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-05-15 5,780 $0.00 5,780 $60.45
Common Stock Stock Option (Right to Buy) Acquisiton 2017-05-15 5,703 $0.00 5,703 $71.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-13 No 4 M Direct
5,703 2018-05-15 2023-05-15 No 4 A Direct
Footnotes
  1. This amendment is filed solely to report the transactions that were inadvertently omitted from the Reporting Person's Form 4 filed on May 17, 2017.
  2. Exercise of stock options awarded under the issuer's incentive compensation plan.
  3. Annual director stock grant under the issuer's incentive compensation plan.
  4. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
  5. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.75 to $71.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2013 grant date.
  7. Annual director stock option grant under the issuer's incentive compensation plan.
  8. Option becomes exercisable in one-third increments beginning on the first anniversary of the grant date.